Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Debt to Equity (2020 - 2025)

Historic Debt to Equity for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $1.56.

  • Bioventus' Debt to Equity fell 2418.98% to $1.56 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.56, marking a year-over-year decrease of 2418.98%. This contributed to the annual value of $1.81 for FY2024, which is 126.65% up from last year.
  • Bioventus' Debt to Equity amounted to $1.56 in Q3 2025, which was down 2418.98% from $1.7 recorded in Q2 2025.
  • Bioventus' Debt to Equity's 5-year high stood at $2.05 during Q3 2024, with a 5-year trough of $0.59 in Q4 2021.
  • Over the past 5 years, Bioventus' median Debt to Equity value was $1.65 (recorded in 2023), while the average stood at $1.39.
  • Its Debt to Equity has fluctuated over the past 5 years, first plummeted by 5495.42% in 2021, then surged by 16268.11% in 2023.
  • Bioventus' Debt to Equity (Quarter) stood at $0.59 in 2021, then surged by 72.3% to $1.01 in 2022, then skyrocketed by 76.07% to $1.79 in 2023, then rose by 1.27% to $1.81 in 2024, then dropped by 13.93% to $1.56 in 2025.
  • Its Debt to Equity was $1.56 in Q3 2025, compared to $1.7 in Q2 2025 and $1.87 in Q1 2025.